Del Mar, CA, United States of America

Thomas Arrhenius



 

Average Co-Inventor Count = 8.5

ph-index = 3

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 2006-2012

Loading Chart...
Loading Chart...
Loading Chart...
14 patents (USPTO):

Title: Thomas Arrhenius: Innovator in Metabolic Modulation

Introduction

Thomas Arrhenius is a prominent inventor based in Del Mar, California. He has made significant contributions to the field of metabolic modulation, holding a total of 14 patents. His work focuses on developing novel compounds that can treat various metabolic diseases.

Latest Patents

Among his latest patents, Arrhenius has developed malonyl-CoA decarboxylase inhibitors that are useful as metabolic modulators. These inventions relate to novel compounds and their prodrugs, as well as pharmaceutical compositions that can treat metabolic diseases. Specifically, his work addresses the inhibition of malonyl-coenzyme A decarboxylase, which is crucial in managing cardiovascular diseases, diabetes, acidosis, cancers, and obesity. Another significant patent involves azoles as malonyl-CoA decarboxylase inhibitors, which also target similar metabolic diseases through innovative compounds and compositions.

Career Highlights

Arrhenius is currently associated with Chugai Seiyaku Kabushiki Kaisha, where he continues to advance his research and development efforts. His career is marked by a commitment to improving health outcomes through innovative solutions in metabolic health.

Collaborations

He has collaborated with notable colleagues, including Jie Fei Cheng and Mi Chen, to further enhance the impact of his research.

Conclusion

Thomas Arrhenius stands out as a key figure in the field of metabolic modulation, with a focus on innovative treatments for serious health conditions. His contributions through patents and collaborations continue to shape the future of metabolic disease management.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…